- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Vector Science and Therapeutics Corp: Vector partners with Caresyntax on VectorMist data | 1 | Stockwatch | ||
| Fr | Vector Science & Therapeutics and Caresyntax Announce Real-World Evidence Partnership for VectorMist | 1 | CNW | ||
| Mi | Vector Science and Therapeutics Corp: Vector files 15 patent applications over two years | 1 | Stockwatch | ||
| Mi | Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic Administration Technologies | 2 | CNW | ||
| 09.07. | Vector Science and Therapeutics Corp: Vector Science appoints Drake as Valor president | 1 | Stockwatch | ||
| 08.07. | Valor by Vector Science & Therapeutics: Darryl Drake Jr. Named President of Valor as Vector Science and Therapeutics Targets the Performance Medicine Market | 420 | PR Newswire | SAN BERNARDINO, Calif., July 8, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. (TSXV: PAIN), a pharmaceutical-grade peptide and precision drug delivery company, today announced... ► Artikel lesen | |
| VECTOR SCIENCE AND THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 08.07. | Vector Science and Therapeutics Corp: Vector, LyoGenesis enter licensing, manufacturing deal | 2 | Stockwatch | ||
| 07.07. | Vector Science & Therapeutics Announces Landmark Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus for Its Proprietary Peptide Portfolio | 2 | CNW | ||
| 01.07. | Vector Science and Therapeutics Corp: Vector Science files provisional patent application | 1 | Stockwatch | ||
| 30.06. | Vector Sciences & Therapeutics: Vector Science & Therapeutics Files Provisional Patent for Breakthrough Transdermal Peptide Delivery Platform | 161 | PR Newswire | Proprietary Magnetic Patch System Delivers Regenerative Peptides to Targeted Tissue Without Injection, with Built-In Confirmation of Successful Delivery
MEQUON... ► Artikel lesen | |
| 22.06. | Vector Science and Therapeutics Corp: Vector names NBA'er Payton II as athletic ambassador | 2 | Stockwatch | ||
| 12.06. | Vector Science and Therapeutics Corp: Vector names x-MLB Fowler chief athletic officer, Valor | 2 | Stockwatch | ||
| 12.06. | Vector Sciences & Therapeutics: Vector Science & Therapeutics Names Dexter Fowler as Chief Athletic Officer for Its Valor Platform | 204 | PR Newswire | 14-Year MLB Veteran and 2016 World Series Champion Joins Valor, Vector's Athlete Platform, to Make Sure the Next Generation Plays Longer and Hurts Less
MEQUON,... ► Artikel lesen | |
| 08.06. | Vector Science and Therapeutics Corp: Vector Science appoints Drake president of Valor unit | 3 | Stockwatch | ||
| 02.06. | Vector Science and Therapeutics Corp: Vector Science grants options to directors | 1 | Stockwatch | ||
| 02.06. | Vector Science & Therapeutics Corp. Grants Options as Company Advances Growth Strategy | 1 | CNW | ||
| 13.05. | Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing | 3 | CNW | ||
| 12.05. | Vector Science and Therapeutics Corp: Vector enters manufacturing deal with MPP Group | 3 | Stockwatch | ||
| 11.05. | Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group LLC | 1 | CNW | ||
| 07.05. | Vector Science and Therapeutics Corp: Vector Science appoints Dobranowski, Kelly to board | 4 | Stockwatch |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADVANCED BIOMED | 9,000 | +1,12 % | Morning Market Movers: Baiya International Group, Globavend, Advanced Biomed, Sadot Group See Big Swings | CANBERA (dpa-AFX) - At 7:25 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 70,54 | +0,06 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600 | NEW YORK, July 14, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent BrightSpring Health Services Inc. (NASD: BTSG) will replace Chart Industries Inc. (NYSE: GTLS)... ► Artikel lesen | |
| FRESENIUS | 42,690 | 0,00 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Fresenius auf "Buy" mit einem Kursziel von 55 Euro belassen. Falko Friedrichs rechnet mit einem guten zweiten Quartal des... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,300 | 0,00 % | BERNSTEIN RESEARCH stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung von Fresenius Medical Care (FMC) mit "Market-Perform" und einem Kursziel von 44,65 Euro gestartet. Mit der Markteinführung... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 26,260 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,340 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,090 | -0,05 % | Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now | ||
| SIEMENS HEALTHINEERS | 35,180 | 0,00 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 38 Euro auf "Neutral" belassen. In der Radiotherapie heiße es nicht mehr nur... ► Artikel lesen | |
| BILLIONTOONE | 125,20 | +0,05 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,740 | 0,00 % | DEUTSCHE BANK RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Carl Zeiss Meditec von 30 auf 28 Euro gesenkt und die Einstufung auf "Hold" belassen. In einem am Dienstag vorliegenden Ausblick... ► Artikel lesen | |
| GENEDX | 60,73 | +0,13 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| AVEANNA HEALTHCARE | 9,690 | 0,00 % | Aveanna Healthcare (AVAH): Best Future Stocks to Buy Under $10 | ||
| PROCEPT BIOROBOTICS | 19,220 | 0,00 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 31,750 | -0,06 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| HEARTFLOW | 24,540 | -0,08 % | Stifel reiterates HeartFlow stock rating after cardiology meeting |
VECTOR SCIENCE AND THERAPEUTICS CORP gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VECTOR SCIENCE AND THERAPEUTICS CORP finden Sie auf Wallstreet Online.